Virtual food in virtual environments for the treatment of eating disorders
Abstract
Eating disorders (Eds) are one of the problems with higher social repercussion in the last years. Sometimes, these clinical syndromes, which are characterized by an altered eating behavior, can have dramatic consequences. In eating disorders, one of the more critical situations, in addition to other of equal or more importance, is the patient's confrontation with food: the visual confrontation, the eating process and the repercussion on his weight. Virtual Reality (VR) technology has been used in psychology, as a therapeutic help tool for the treatment of different psychological problems, for several years now. Their helpfulness is increasingly being recognized. Some developed virtual environments (VE) and their corresponding published studies endorse the efficiency of this tool. Nevertheless, in order to increase the possibilities of success, it is very important to obtain a complete patient immersion in the VE: visual, auditory and interactive. Sometimes there are processes or actions of reality, which are difficult to simulate virtually, and simulating them coarsely would result in the patient lack of immersion in the VE, thus seriously decreasing the possibilities of success. The eating process is an example, since it consists of several steps, some of which (biting, chewing, etc.) don't have an evident virtual solution. This article shows how food and eating process have been simulated virtually in the development of a virtual environment for the treatment of eating…
How strong is the evidence?
Evidence Hub reads this as a clinical trial, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.